Insulin Resistance Accelerates Muscle Protein Degradation: Activation of the Ubiquitin-Proteasome Pathway by Defects in Muscle Cell Signaling
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Conditions such as acidosis, uremia, and sepsis are characterized by insulin resistance and muscle wasting, but whether the insulin resistance associated with these disorders contributes to muscle atrophy is unclear. We examined this question in db/db mice with increased blood glucose despite high levels of plasma insulin. Compared with control littermate mice, the weights of different muscles in db/db mice and the cross-sectional areas of muscles were smaller. In muscle of db/db mice, protein degradation and activities of the major proteolytic systems, caspase-3 and the proteasome, were increased. We examined signals that could activate muscle proteolysis and found low values of both phosphatidylinositol 3 kinase (PI3K) activity and phosphorylated Akt that were related to phosphorylation of serine 307 of insulin receptor substrate-1. To assess how changes in circulating insulin and glucose affect muscle protein, we treated db/db mice with rosiglitazone. Rosiglitazone improved indices of insulin resistance and abnormalities in PI3K/Akt signaling and decreased activities of caspase-3 and the proteasome in muscle leading to suppression of proteolysis. Underlying mechanisms of proteolysis include increased glucocorticoid production, decreased circulating adiponectin, and phosphorylation of the forkhead transcription factor associated with increased expression of the E3 ubiquitin-conjugating enzymes atrogin-1/MAFbx and MuRF1. These abnormalities were also corrected by rosiglitazone. Thus, insulin resistance causes muscle wasting by mechanisms that involve suppression of PI3K/Akt signaling leading to activation of caspase-3 and the ubiquitin-proteasome proteolytic pathway causing muscle protein degradation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased expression of these E3 enzymes in insulin resistant individuals contributes to muscle protein degradation, a mechanism not shared by age-related sarcopenia.47”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [47]
In the citing paper
“In insulin resistance, insulin or IGF-1 signalling is suppressed, leading to downregulation of the phosphatidylinositol 3 kinase/Akt pathway and decreased protein synthesis, as well as to forkhead box protein O1 phosphorylation. Phosphorylated forkhead box protein O1 stimulates expression of the E3 enzymes atrogin-1 and muscle ring finger-1 via increased activation of the ubiquitin-proteasome”
From Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases (2014) · cites this paper as [47]
Citations
Cites
Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections
King, H., Aubert, R. E., & Herman, W. H. (1998) · Diabetes Care · doi:10.2337/diacare.21.9.1414 · Cited by 6,311
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Diet-induced insulin resistance in mice lacking adiponectin/ACRP30
Maeda, N., Shimomura, I., Kishida, K., Nishizawa, H., Matsuda, M., Nagaretani, H., Furuyama, N., Kondo, H., Takahashi, M., Arita, Y., et al. (2002) · Nature Medicine · doi:10.1038/nm724 · Cited by 2,088
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
Lecker, S. H., Jagoe, R. T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., Price, S. R., Mitch, W. E., & Goldberg, A. L. (2004) · The FASEB Journal · doi:10.1096/fj.03-0610com · Cited by 1,539
Self-citationMechanisms of Muscle Wasting — The Role of the Ubiquitin–Proteasome Pathway
Mitch, W. E., & Goldberg, A. L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199612193352507 · Cited by 1,166
Self-citationThiazolidinediones in the Treatment of Insulin Resistance and Type II Diabetes
Saltiel, A. R., & Olefsky, J. M. (1996) · Diabetes · doi:10.2337/diab.45.12.1661 · Cited by 1,053
Aguirre, V., Werner, E. D., Giraud, J., Lee, Y. H., Shoelson, S. E., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m101521200 · Cited by 1,010 · cited 1×
“This change in serine phosphorylation has been linked to decreased insulin responses because of its interference with insulin receptor signaling (25, 26).”
BackgroundDu, J., Wang, X., Miereles, C., Bailey, J. L., Debigare, R., Zheng, B., Price, S. R., & Mitch, W. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18330 · Cited by 731
Self-citation
Cited by
mTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509
Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1
Bodine, S. C., & Baehr, L. M. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00204.2014 · Cited by 1,113
Age-related and disease-related muscle loss: The effect of diabetes, obesity, and other diseases
Kalyani, R. R., Corriere, M., & Ferrucci, L. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70034-8 · Cited by 1,102
Carrero, J. J., Stenvinkel, P., Cuppari, L., Ikizler, T. A., Kalantar-Zadeh, K., Kaysen, G., Mitch, W. E., Price, S. R., Wanner, C., Wang, A. Y. M., et al. (2013) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2013.01.001 · Cited by 939
Self-citationSkeletal muscle performance and ageing
Tieland, M., Trouwborst, I., & Clark, B. C. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12238 · Cited by 904
“contributing to maintenance of a positive muscle protein balance.(196) The resistance to insulin potentially contributes to suppression of these pathways, resulting in a lower net pro-”
Sarcopenia in an Overweight or Obese Patient Is an Adverse Prognostic Factor in Pancreatic Cancer
Tan, B. H. L., Birdsell, L. A., Martin, L., Baracos, V. E., & Fearon, K. C. H. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-1525 · Cited by 653
Mechanisms of muscle wasting in chronic kidney disease
Wang, X. H., & Mitch, W. E. (2014) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.112 · Cited by 616
Self-citationInsulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
The role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 540
Glucocorticoids, metabolism and metabolic diseases
Vegiopoulos, A., & Herzig, S. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.015 · Cited by 535
“Although GC levels are generally found to be normal in obese individuals [143], elevated corticosterone production was measured in obese db/db mice [212].”
BackgroundExcess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J. (2007) · Diabetes · doi:10.2337/db07-0093 · Cited by 520
Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M., Bradshaw, P. T., Kwan, M. L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2319 · Cited by 427
Waddell, D. S., Baehr, L. M., van den Brandt, J., Johnsen, S. A., Reichardt, H. M., Furlow, J. D., & Bodine, S. C. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00646.2007 · Cited by 359
The role and regulation of MAFbx/atrogin-1 and MuRF1 in skeletal muscle atrophy
Foletta, V. C., White, L. J., Larsen, A. E., Léger, B., & Russell, A. P. (2011) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-010-0919-9 · Cited by 357
Metabolic changes in aging humans: current evidence and therapeutic strategies
Palmer, A. K., & Jensen, M. D. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158451 · Cited by 331
Alterations of protein turnover underlying disuse atrophy in human skeletal muscle
Phillips, S. M., Glover, E. I., & Rennie, M. J. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00452.2009 · Cited by 322
“The UPP cannot, however, degrade intact myofibrils (62, 77, 107, 121) and so enzymatic 274 cleavage of ‘susceptible’ sites in the myofibrillar lattice is thought to occur via either activated 275 calpain (37, 137) or caspase-3 (35, 42, 135).”
Adiponectin action from head to toe
Brochu-Gaudreau, K., Rehfeldt, C., Blouin, R., Bordignon, V., Murphy, B. D., & Palin, M.-F. (2010) · Endocrine · doi:10.1007/s12020-009-9278-8 · Cited by 322
Role of Dietary Proteins and Amino Acids in the Pathogenesis of Insulin Resistance
Tremblay, F., Lavigne, C., Jacques, H., & Marette, A. (2007) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.25.050304.092545 · Cited by 319
Perry, B. D., Caldow, M. K., Brennan‐Speranza, T. C., Sbaraglia, M., Jerums, G., GARNHAM, A. P., Wong, C. Y., Levinger, P., Haq, M. A. U., Hare, D. L., et al. (2016) · PubMed · Cited by 318
Cancer cachexia: molecular mechanisms and treatment strategies
Setiawan, T., Sari, I. N., Wijaya, Y. T., Julianto, N. M., Muhammad, J. A., Lee, H., Chae, J. H., & Kwon, H. Y. (2023) · Journal of Hematology & Oncology · doi:10.1186/s13045-023-01454-0 · Cited by 315
Myostatin/activin pathway antagonism: molecular basis and therapeutic potential
Han, H. Q., Zhou, X., Mitch, W. E., & Goldberg, A. L. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.019 · Cited by 314
Self-citationVanweert, F., Schrauwen, P., & Phielix, E. (2022) · Nutrition & Diabetes · doi:10.1038/s41387-022-00213-3 · Cited by 289
Review of muscle wasting associated with chronic kidney disease
Workeneh, B. T., & Mitch, W. E. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2010.28608b · Cited by 280
Self-citationFrailty, Sarcopenia and Diabetes
Morley, J. E., Malmstrom, T. K., Rodriguez-Mañas, L., & Sinclair, A. J. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2014.10.001 · Cited by 277
Cachexia: A systemic consequence of progressive, unresolved disease
Ferrer, M., Anthony, T. G., Ayres, J. S., Biffi, G., Brown, J. C., Caan, B. J., Cespedes Feliciano, E. M., Coll, A. P., Dunne, R. F., Goncalves, M. D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.028 · Cited by 260
The role of E3 ubiquitin-ligases MuRF-1 and MAFbx in loss of skeletal muscle mass
Rom, O., & Reznick, A. Z. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.12.031 · Cited by 256
Protein damage, repair and proteolysis
Chondrogianni, N., Petropoulos, I., Grimm, S., Georgila, K., Catalgol, B., Friguet, B., Grune, T., & Gonos, E. S. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.09.001 · Cited by 256
Hwang, H., Bowen, B. P., Lefort, N., Flynn, C. R., De Filippis, E. A., Roberts, C., Smoke, C. C., Meyer, C., Højlund, K., Yi, Z., et al. (2010) · Diabetes · doi:10.2337/db09-0214 · Cited by 255
The role of FOXO in the regulation of metabolism
Gross, D. N., Wan, M., & Birnbaum, M. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0034-5 · Cited by 240
IL-6 and Serum Amyloid A Synergy Mediates Angiotensin II–Induced Muscle Wasting
Zhang, L., Du, J., Hu, Z., Han, G., Delafontaine, P., Garcia, G., & Mitch, W. E. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008060628 · Cited by 240
Self-citationA systematic review of p53 regulation of oxidative stress in skeletal muscle
Beyfuss, K., & Hood, D. A. (2018) · Redox Report · doi:10.1080/13510002.2017.1416773 · Cited by 239
Hyperglycemia Predicts Persistently Lower Muscle Strength With Aging
Kalyani, R. R., Metter, E. J., Egan, J., Golden, S. H., & Ferrucci, L. (2015) · Diabetes Care · doi:10.2337/dc14-1166 · Cited by 236
Metabolic Impairment in Heart Failure
Doehner, W., Frenneaux, M., & Anker, S. D. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.04.083 · Cited by 236
Varma, V., Yao-Borengasser, A., Rasouli, N., Nolen, G. T., Phanavanh, B., Starks, T., Gurley, C., Simpson, P., McGehee, R. E., Kern, P. A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90885.2008 · Cited by 229
Silva, K. A. S., Dong, J., Dong, Y., Dong, Y., Schor, N., Tweardy, D. J., Zhang, L., & Mitch, W. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.641514 · Cited by 229
Self-citationInflammaging: Implications in Sarcopenia
Antuña, E., Cachán-Vega, C., Bermejo-Millo, J. C., Potes, Y., Caballero, B., Vega-Naredo, I., Coto-Montes, A., & Garcia-Gonzalez, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315039 · Cited by 215
Links between metabolic syndrome and metabolic dysfunction-associated fatty liver disease
Lim, S., Kim, J.-W., & Targher, G. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2021.04.008 · Cited by 213
Association of handgrip strength with chronic diseases and multimorbidity: A cross-sectional study
Cheung, C.-L., Nguyen, U.-S. D. T., Au, E., Tan, K. C. B., & Kung, A. W. C. (2013) · AGE · doi:10.1007/s11357-012-9385-y · Cited by 212
Intracellular cAMP Sensor EPAC: Physiology, Pathophysiology, and Therapeutics Development
Robichaux, W. G., & Cheng, X. (2018) · Physiological Reviews · doi:10.1152/physrev.00025.2017 · Cited by 208
Sarcopenia and cardiovascular diseases: A systematic review and meta‐analysis
Zuo, X., Li, X., Tang, K., Zhao, R., Wu, M., Wang, Y., & Li, T. (2023) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.13221 · Cited by 207
Diabetes and Altered Glucose Metabolism with Aging
Kalyani, R. R., & Egan, J. M. (2013) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.02.010 · Cited by 207
Satellite Cell Dysfunction and Impaired IGF-1 Signaling Cause CKD-Induced Muscle Atrophy
Zhang, L., Wang, X. H., Wang, H., Du, J., & Mitch, W. E. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009060571 · Cited by 206
Self-citationHu, Z., Wang, H., Lee, I. H., Du, J., & Mitch, W. E. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38770 · Cited by 205
Self-citationHyperglycemia Impairs Proteasome Function by Methylglyoxal
Queisser, M. A., Yao, D., Geisler, S., Hammes, H.-P., Lochnit, G., Schleicher, E. D., Brownlee, M., & Preissner, K. T. (2010) · Diabetes · doi:10.2337/db08-1565 · Cited by 198
Understanding cachexia in the context of metastatic progression
Biswas, A. K., & Acharyya, S. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0251-4 · Cited by 197
Gu, J., Cheng, Y., Wu, H., Kong, L., Wang, S., Xu, Z., Zhang, Z., Tan, Y., Keller, B. B., Zhou, H., et al. (2017) · Diabetes · doi:10.2337/db15-1274 · Cited by 196
Crossland, H., Constantin‐Teodosiu, D., Gardiner, S. M., Constantin, D., & Greenhaff, P. L. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160150 · Cited by 184
Siew, E. D., Pupim, L. B., Majchrzak, K. M., Shintani, A., Flakoll, P. J., & Ikizler, T. A. (2007) · Kidney International · doi:10.1038/sj.ki.5001984 · Cited by 170
Updates on the Management of Diabetes in Dialysis Patients
Rhee, C. M., Leung, A. M., Kovesdy, C. P., Lynch, K. E., Brent, G. A., & Kalantar‐Zadeh, K. (2014) · Seminars in Dialysis · doi:10.1111/sdi.12198 · Cited by 169
HMB supplementation: clinical and athletic performance-related effects and mechanisms of action
Zanchi, N. E., Gerlinger-Romero, F., Guimarães-Ferreira, L., de Siqueira Filho, M. A., Felitti, V., Lira, F. S., Seelaender, M., & Lancha, A. H. (2011) · Amino Acids · doi:10.1007/s00726-010-0678-0 · Cited by 151
The role of insulin resistance in the development of muscle wasting during cancer cachexia
Honors, M. A., & Kinzig, K. P. (2012) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1007/s13539-011-0051-5 · Cited by 167
miRNA‐23a/27a attenuates muscle atrophy and renal fibrosis through muscle‐kidney crosstalk
Zhang, A., Li, M., Wang, B., Klein, J. D., Price, S. R., & Wang, X. H. (2018) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12296 · Cited by 149
Self-citationMechanisms Underlying Metabolic Syndrome-Related Sarcopenia and Possible Therapeutic Measures
Rubio-Ruiz, M. E., Guarner-Lans, V., Pérez-Torres, I., & Soto, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030647 · Cited by 165
Clinical implications of sarcopenic obesity in cancer
Carneiro, I. P., Mazurak, V. C., & Prado, C. M. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0546-5 · Cited by 162
Hamed, S. A. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1555468 · Cited by 162
New roles for desmin in the maintenance of muscle homeostasis
Agnetti, G., Herrmann, H. O., & Cohen, S. (2021) · FEBS Journal · doi:10.1111/febs.15864 · Cited by 162
Metabolic syndrome and chronic kidney disease: Current status and future directions
Prasad, G. R. (2014) · World Journal of Nephrology · doi:10.5527/wjn.v3.i4.210 · Cited by 161
Ono, Y., Maejima, Y., Saito, M., Sakamoto, K., Horita, S., Shimomura, K., Inoue, S., & Kotani, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-57714-3 · Cited by 161
Wang, B., Zhang, A., Wang, H., Klein, J. D., Tan, L., Wang, Z.-M., Du, J., Naqvi, N., Liu, B.-C., & Wang, X. H. (2019) · Theranostics · doi:10.7150/thno.29579 · Cited by 160
Self-citationZhou, Q. G., Hou, F. F., Guo, Z. J., Liang, M., Wang, G. B., & Zhang, X. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.873 · Cited by 145
Frailty Status and Altered Glucose-Insulin Dynamics
Kalyani, R. R., Varadhan, R., Weiss, C. O., Fried, L. P., & Cappola, A. R. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glr141 · Cited by 139
Insulin resistance and the metabolism of branched-chain amino acids
Lu, J., Xie, G., Jia, W., & Jia, W. P. (2013) · Frontiers of Medicine · doi:10.1007/s11684-013-0255-5 · Cited by 153
Sarcopenia, Frailty, and Diabetes in Older Adults
Jang, H. C. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.3.182 · Cited by 135
MicroRNA-29 induces cellular senescence in aging muscle through multiple signaling pathways
Hu, Z., Klein, J. D., Mitch, W. E., Zhang, L., Martinez, I., & Wang, X. H. (2014) · Aging · doi:10.18632/aging.100643 · Cited by 140
Self-citationImpaired Muscle Regeneration in Ob/ob and Db/db Mice
Nguyen, M.-H., Cheng, M., & Koh, T. J. (2011) · The Scientific World JOURNAL · doi:10.1100/tsw.2011.137 · Cited by 129
Ghrelin Treatment of Chronic Kidney Disease: Improvements in Lean Body Mass and Cytokine Profile
DeBoer, M. D., Zhu, X., Levasseur, P. R., Inui, A., Hu, Z., Han, G., Mitch, W. E., Taylor, J. E., Halem, H. A., Dong, J. Z., et al. (2008) · Endocrinology · doi:10.1210/en.2007-1046 · Cited by 141
Self-citationSarcopenia in Chronic Kidney Disease
de Souza, V. A., de Oliveira, D., Mansur, H. N., Fernandes, N. M. D. S., & Bastos, M. G. (2015) · Brazilian Journal of Nephrology · doi:10.5935/0101-2800.20150014 · Cited by 148
PTEN Inhibition Improves Muscle Regeneration in Mice Fed a High-Fat Diet
Hu, Z., Wang, H., Lee, I. H., Modi, S., Wang, X., Du, J., & Mitch, W. E. (2010) · Diabetes · doi:10.2337/db09-1155 · Cited by 136
Self-citationOtoda, T., Takamura, T., Misu, H., Ota, T., Murata, S., Hayashi, H., Takayama, H., Kikuchi, A., Kanamori, T., Shima, K. R., et al. (2013) · Diabetes · doi:10.2337/db11-1652 · Cited by 131
Sarcopenia in chronic liver disease: mechanisms and countermeasures
Allen, S., Quinlan, J. I., Dhaliwal, A., Armstrong, M. J., Elsharkawy, A. M., Greig, C. A., Lord, J. M., Lavery, G. G., & Breen, L. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00373.2020 · Cited by 144
Sebastiano, K. M. D., Yang, L., Zbuk, K. M., Wong, R. K. W., Chow, T., Koff, D., Moran, G. R., & Mourtzakis, M. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001067 · Cited by 141
Wang, X. H., Du, J., Klein, J. D., Bailey, J. L., & Mitch, W. E. (2009) · Kidney International · doi:10.1038/ki.2009.260 · Cited by 128
Self-citationMetabolic benefits of resistance training and fast glycolytic skeletal muscle
LeBrasseur, N. K., Walsh, K., & Arany, Z. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00512.2010 · Cited by 118
Nakazawa, H., Chang, K., Shinozaki, S., Yasukawa, T., Ishimaru, K., Yasuhara, S., Yu, Y.-M., Martyn, J. A. J., Tompkins, R. G., Shimokado, K., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170391 · Cited by 117
Mitochondrial dysfunction and skeletal muscle atrophy: Causes, mechanisms, and treatment strategies
Kubat, G. B., Bouhamida, E., Ülger, Ö., Türkel, İ., Pedriali, G., Ramaccini, D., Ekinci, Ö., Özerkliğ, B., Atalay, Ö., Patergnani, S., et al. (2023) · Mitochondrion · doi:10.1016/j.mito.2023.07.003 · Cited by 137
Role of glucocorticoids in the molecular regulation of muscle wasting
Menconi, M., Fareed, M., O’Neal, P., Poylin, V., Wei, W., & Hasselgren, P.-O. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000279194.11328.77 · Cited by 115
Qiao, Y.-S., Chai, Y.-H., Gong, H.-J., Zhuldyz, Z., Stehouwer, C. D. A., Zhou, J.-B., & Simó, R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.782391 · Cited by 132
“First, insulin resistance, through inhibition of the mTOR pathway (46), activation of autophagy (46), activation of the ubiquitinproteasome proteolytic pathway (47), and accelerated muscle protein degradation may cause sarcopenia.”
BackgroundYang, M., Wei, D., Mo, C., Zhang, J., Wang, X., Han, X., Wang, Z., & Xiao, H. (2013) · Lipids in Health and Disease · doi:10.1186/1476-511x-12-104 · Cited by 115
Self-citationUSP1 deubiquitinates Akt to inhibit PI3K‐Akt‐FoxO signaling in muscle during prolonged starvation
Goldbraikh, D., Neufeld, D., Eid‐Mutlak, Y., Lasry, I., Gilda, J. E., Parnis, A., & Cohen, S. (2020) · EMBO Reports · doi:10.15252/embr.201948791 · Cited by 131
Oral Drugs Related with Muscle Wasting and Sarcopenia. A Review
Campins, L., Camps, M. V., Riera, A., Pleguezuelos, E., Yébenes, J. C., & Serra‐Prat, M. (2016) · Pharmacology · doi:10.1159/000448247 · Cited by 130
Yang, Y. J., & Kim, D. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052604 · Cited by 112
Sarcopenia as a comorbidity of cardiovascular disease
Sasaki, K., & Fukumoto, Y. (2021) · Journal of Cardiology · doi:10.1016/j.jjcc.2021.10.013 · Cited by 128
Molecular mechanisms of insulin resistance in chronic kidney disease
Thomas, S. S., Zhang, L., & Mitch, W. E. (2015) · Kidney International · doi:10.1038/ki.2015.305 · Cited by 111
Self-citationAmino acid metabolism and regulatory effects in aging
Timmerman, K. L., & Volpi, E. (2008) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e3282f2a592 · Cited by 112
Minireview: New Molecular Mediators of Glucocorticoid Receptor Activity in Metabolic Tissues
Patel, R., Williams-Dautovich, J., & Cummins, C. L. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1062 · Cited by 108
Aluganti Narasimhulu, C., & Singla, D. K. (2021) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12662 · Cited by 106
Factors mediating spaceflight-induced skeletal muscle atrophy
Lee, P. H. U., Chung, M., Ren, Z., Mair, D. B., & Kim, D. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00203.2021 · Cited by 122
Insulin Regulation of Proteostasis and Clinical Implications
James, H. A., O'Neill, B. T., & Nair, K. S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.06.010 · Cited by 121
Perkisas, S., & Vandewoude, M. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2743 · Cited by 120
Marzocco, S., Fazeli, G., Micco, L. D., Autore, G., Adesso, S., Piaz, F. D., Heidland, A., & Iorio, B. R. D. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7100315 · Cited by 119
Non-Alcoholic Fatty Liver Disease in Lean and Non-Obese Individuals: Current and Future Challenges
Kuchay, M. S., Martínez‐Montoro, J. I., Choudhary, N. S., Fernández‐García, J. C., & Ramos‐Molina, B. (2021) · Biomedicines · doi:10.3390/biomedicines9101346 · Cited by 118
Zhou, Q., Du, J., Hu, Z., Walsh, K., & Wang, X. H. (2007) · Endocrinology · doi:10.1210/en.2007-0183 · Cited by 103
Self-citationPrevalence and Mechanisms of Skeletal Muscle Atrophy in Metabolic Conditions
Jun, L., Robinson, M., Geetha, T., Broderick, T. L., & Babu, J. R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032973 · Cited by 115
Decreased miR-29 Suppresses Myogenesis in CKD
Wang, X. H., Hu, Z., Klein, J. D., Zhang, L., Fang, F., & Mitch, W. E. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121278 · Cited by 110
Self-citationYang, Z., & Ming, X. (2012) · Obesity Reviews · doi:10.1111/j.1467-789x.2012.01038.x · Cited by 97
Optimal Nutrition in Hemodialysis Patients
Ikizler, T. A. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2012.12.002 · Cited by 112
Diabetes pharmacotherapy and effects on the musculoskeletal system
Kalaitzoglou, E., Fowlkes, J. L., Popescu, I., & Thrailkill, K. M. (2019) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3100 · Cited by 100
Fung, F. Y., Koh, Y. L. E., Malhotra, R., Østbye, T., Lee, P. Y., Ghazali, S. S., & Tan, N. C. (2019) · BMC Geriatrics · doi:10.1186/s12877-019-1137-8 · Cited by 110
Tong, J. F., Yan, X., Zhu, M. J., & Du, M. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22272 · Cited by 98
Ninomiya, G., Fujii, T., Yamada, S., Yabusaki, N., Suzuki, K., Iwata, N., Kanda, M., Hayashi, M., Tanaka, C., Nakayama, G., et al. (2017) · International Journal of Surgery · doi:10.1016/j.ijsu.2017.01.075 · Cited by 101
Metadata
- Authors
- Wang, X., Hu, Z., Hu, J., Du, J., & Mitch, W. E.
- Affiliations
- Emory University (US)
- Baylor College of Medicine (US)
- Corresponding author
- Wang, Xiaonan
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-09-01
- Volume
- 147
- Issue
- 9
- Pages
- 4160-4168
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2159744672
- Cited by
- 600
- References
- 42
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 24 · 2023: 30 · 2022: 29 · 2021: 44 · 2020: 35 · 2019: 45 · 2018: 29 · 2017: 34 · 2016: 26 · 2015: 31 · 2014: 42 · 2013: 35 · 2012: 24
- FWCI
- 10.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Emory University
- National Institutes of Health (NIH-R01, NIH P50)
- School of Medicine, Emory University
- National Heart, Lung, and Blood Institute (R01HL070762, HL70762)
- National Institute of Diabetes and Digestive and Kidney Diseases (P50DK064233, R01 DK 37175, R21DK062796, R37DK037175, R21 DK62796, R01DK037175)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, muscle protein degradation, muscle atrophy, ubiquitin-proteasome system, PI3K/Akt signaling, IRS-1, caspase-3, rosiglitazone, db/db mice, glucocorticoids, adiponectin, atrogin-1/MAFbx, MuRF1, E3 ubiquitin ligase
- MeSH terms
- Rosiglitazone, Animals, Blood Glucose, Hypoglycemic Agents, Insulin, Insulin Resistance, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Muscle Proteins, Muscular Atrophy, Phosphorylation, RNA, Messenger, Tumor Necrosis Factor-alpha, Signal Transduction, Interleukin-6, Gene Expression, Muscle, Skeletal, Phosphatidylinositol 3-Kinases, Reverse Transcriptase Polymerase Chain Reaction, Caspases, Ubiquitin, Muscle Cells, 3T3-L1 Cells, Thiazolidinediones, Proteasome Endopeptidase Complex, Proto-Oncogene Proteins c-akt, Mice, Adiponectin, Caspase 3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.